LGALS1 and hepatocellular carcinoma: This demonstrates that the increase in the level of soluble galectin-1 can provide the chemoresistacnce to hepatocellular carcinoma towards the cisplatin treatment which confirms the role of soluble galectin-1 as similar to the above findings of endogenous galectin-1.